2,3,7,8-tetrachlorodibenzo-p-dioxin augments the modulation of gene expression mediated by the thyroid hormone receptor
- 1 February 2004
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 194 (3) , 201-210
- https://doi.org/10.1016/j.taap.2003.09.010
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 40 references indexed in Scilit:
- Thyroid hormone induces the expression of 4-1BB and activation of caspases in a thyroid hormone receptor-dependent mannerEuropean Journal of Biochemistry, 2003
- PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppressionNature, 2003
- Correlation Between Toxicity and Effects on Intermediary Metabolism in 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Treated Male C57BL/6J and DBA/2J MiceToxicology and Applied Pharmacology, 1995
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Molecular complexes of thyroid hormone tyrosyl rings with aromatic donors. Possible relationship to receptor protein interactionsJournal of Medicinal Chemistry, 1988
- Evidence that 2,3,7,8-tetrachlorodibenzo-p-dioxin and thyroid hormones act through different mechanisms in human keratinocytesToxicology and Applied Pharmacology, 1987
- Effects of thyroid hormones on the induction of cleft palate by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL6N miceToxicology and Applied Pharmacology, 1986
- Human Dioxin-Inducible Cytochrome P 1 -450: Complementary DNA and Amino Acid SequenceScience, 1985
- Effect of thyroidectomy and thyroxine on 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induced toxicityToxicology and Applied Pharmacology, 1984
- Human pregnancy‐specific beta1‐globulin and its relation to chorioepitheliomaInternational Journal of Cancer, 1976